SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-010315
Filing Date
2023-02-10
Accepted
2023-02-10 16:30:41
Documents
46
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q1222_citiuspharma.htm   iXBRL 10-Q 394181
2 CERTIFICATION f10q1222ex31-1_citiuspharma.htm EX-31.1 10920
3 CERTIFICATION f10q1222ex31-2_citiuspharma.htm EX-31.2 10507
4 CERTIFICATION f10q1222ex32-1_citiuspharma.htm EX-32.1 5985
  Complete submission text file 0001213900-23-010315.txt   2867925

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE ctxr-20221231.xsd EX-101.SCH 44957
6 XBRL CALCULATION FILE ctxr-20221231_cal.xml EX-101.CAL 23796
7 XBRL DEFINITION FILE ctxr-20221231_def.xml EX-101.DEF 149687
8 XBRL LABEL FILE ctxr-20221231_lab.xml EX-101.LAB 342190
9 XBRL PRESENTATION FILE ctxr-20221231_pre.xml EX-101.PRE 162445
40 EXTRACTED XBRL INSTANCE DOCUMENT f10q1222_citiuspharma_htm.xml XML 254675
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

IRS No.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-38174 | Film No.: 23612530
SIC: 2834 Pharmaceutical Preparations